Clinical trial
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
NCT03528902
Study timeline
Study start (actual)2018-10-01Date precision: day
Registry last updated2024-12-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertensionunresolved
Pulmonary Arterial Hypertensionunresolved
Familial Primary Pulmonary Hypertensionunresolved
Primary Pulmonary Hypertensionunresolved
Lung Diseasesunresolved
Tamoxifenunresolved
Estrogen Receptor Antagonistunresolved
Hormone Antagonistsunresolved
Estrogensunresolved
Interventions
TamoxifenDRUG · verified · RxNorm: tamoxifen
Sponsors & collaborators
Vanderbilt University Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03528902 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.